President & Chief Executive Officer, Amerigen Pharmaceuticals, Inc.
John Lowry was appointed President & CEO of Amerigen in 2010. Mr. Lowry has nearly 30 years of experience, most of which is in leading product development organizations and global businesses in the pharmaceutical and medical device industries.
Most recently, Mr. Lowry was CEO of Catalent Pharma Solutions, a $1.7 billion leading provider of contract development, manufacturing and drug delivery technologies to global pharmaceutical and biotechnology customers. Prior to Catalent, he held several leadership positions for Cardinal Health, including Group President of Pharmaceutical Technologies and Services and President of R.P. Scherer. Mr. Lowry previously was President of Becton Dickinson’s (BD) Worldwide Diabetes Healthcare/Consumer Healthcare business and began his time at BD as Vice President of BD Medical Systems R&D.
Mr. Lowry spent the first 15 years of his career at GE, most recently at GE Healthcare. He holds a BSME from Villanova University.